Gland Pharma Ltd. (GLAND) Share Price Hits Fresh 52-Week High

Gland Pharma Ltd. Share Price is at Rs 2635.4 today, up 1.34% or Rs 34.95 from the previous close of Rs 2600.45, after the stock hit a fresh 52-week high of Rs 2675.15. The company’s market capitalisation stands at Rs 42,898.76 crore, placing the move firmly on the radar of investors tracking Healthcare names in the Indian stock market.

This Gland Pharma Ltd. Share Price Today move matters because a fresh one-year high often signals renewed market attention, even when the verified data does not establish a company-specific catalyst. Based on the supplied screener data, what is confirmed is the price event itself: GLAND opened at Rs 2639.6, traded between Rs 2610.1 and Rs 2675.15, and recorded turnover of Rs 3.46 crore with volume of 13,114 shares by 10 August 2026 at 10:16 AM IST.

For investors searching for Gland Pharma Ltd. Stock News, the immediate takeaways are straightforward. The stock has pushed to a new yearly high, it remains near that elevated zone, and its valuation and profitability profile present a mixed fundamental backdrop. Univest notes that while the price action is strong enough to place the stock among closely watched 52 Week High Stocks, investors should also monitor how the current valuation, sector positioning and peer metrics compare with the broader Healthcare benchmark.

Gland Pharma Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 2,635.4
Previous Close	Rs 2,600.45
Today's Change	+Rs 34.95 (+1.34%)
Day Open	Rs 2,639.6
Fresh 52-Week High	Rs 2,675.15
Day Low	Rs 2,610.1
Current Volume	13,114
Turnover	Rs 3.46 crore
Market Capitalisation	Rs 42,898.76 crore

Gland Pharma Ltd. (GLAND) traded at Rs 2,635.4. versus the previous close of Rs 2,600.45, a rise of 1.34%. The stock opened at Rs 2,639.6, reached Rs 2,675.15, touched Rs 2,610.1. Reported volume was 13,114.

Gland Pharma Ltd. Share Price Today reflects a clear 52-week high event: the stock opened above the previous close, moved to a new yearly high of Rs 2675.15, and stayed positive at Rs 2635.4. That intraday structure shows sustained attention, while turnover of Rs 3.46 crore and volume of 13,114 shares confirm active participation.

In absolute terms, Gland Pharma Ltd. Share Price added Rs 34.95 over the previous close of Rs 2600.45, translating into a gain of 1.34%. The session began at Rs 2639.6, slipped to an intraday low of Rs 2610.1, and then stretched to the 52-week peak of Rs 2675.15. That means the stock not only registered a fresh one-year high but also traded in a relatively contained band after opening higher.

For traders and long-term market participants alike, this kind of price action often attracts attention in Stock Market Today and Share Market Today screens because it combines positive day change with a new high watermark. The supplied data confirms that GLAND is trending due to the breakout in price, though it does not identify a separate company announcement or event as the reason.

From a market structure perspective, the fact that the stock is still below the session high but above the previous close suggests that investors are now watching whether this 52-week peak turns into a stable reference point for further price discovery. That is why Gland Pharma Ltd. Share Price Update searches are likely to remain elevated, and why the next step is to examine whether the fundamentals support this attention.

Gland Pharma Ltd. (GLAND) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 42,898.76 crore
P/E Ratio	31.12x
P/B Ratio	0.45x
ROE	-2.89%
ROCE	-0.26%

Gland Pharma Ltd. was valued at a P/E ratio of 31.12x, a P/B ratio of 0.45x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	31.12x
Benchmark Median P/E	21.04x
Benchmark Average P/E	71.82x
Benchmark P/E Range	0x to 3,417.8x
Company P/B Ratio	0.45x
Benchmark Median P/B	1.89x
Company ROE	-2.89%
Benchmark Median ROE	10.7%
Company ROCE	-0.26%
Benchmark Median ROCE	13.16%
Company Market Capitalisation	Rs 42,898.76 crore
Benchmark Median Market Cap	Rs 130.8 crore

Gland Pharma Ltd. (GLAND) is classified under sector: Healthcare.

Gland Pharma Ltd. (GLAND) has a P/E ratio of 31.12x, which is above the benchmark median of 21.04x, a difference of +47.91%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Gland Pharma Ltd. (GLAND) has a ROE of -2.89%, which is below the benchmark median of 10.7%, a difference of -127.01%. Gland Pharma Ltd. (GLAND) has a ROCE of -0.26%, which is below the benchmark median of 13.16%, a difference of -101.98%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	3,032.97	31.12	0.45	-2.89	-0.26
Kwality Pharmaceuticals Ltd.	KPL	2,707.2	40.2	8.18	28.21	26.35
Beta Drugs Ltd.	BETA	2,631.45	63.43	6.27	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,537.93	33.3	6.87	-2.6	16.92
Sai Parenteral's Ltd.	SAIPARENT	2,513.58	176.28	3.26	13.9	12.97

Gland Pharma Ltd. (GLAND) has a P/E ratio of 31.12x compared with the displayed peer median of 40.2x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Gland Pharma Ltd. (GLAND) has a market capitalisation of Rs 42,898.76 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Gland Pharma Ltd.

This stock is attracting attention because the verified data combines a fresh 52-week high with a sizeable market capitalisation and a valuation-profitability mix that is not straightforward. For investors following Breakout Stocks, Momentum Stocks and daily Stock Updates, these are the core points to monitor.

• Fresh price milestone: Gland Pharma Ltd. Share Price touched a new 52-week peak of Rs 2675.15 and remained up 1.34% at Rs 2635.4.
• Positive intraday structure: The stock opened at Rs 2639.6, traded between Rs 2610.1 and Rs 2675.15, and held above the previous close of Rs 2600.45.
• Active participation: Turnover stood at Rs 3.46 crore with volume of 13,114 shares, keeping GLAND in focus in Trading Volume and Price Action screens.
• Valuation context: P/E at 31.12 is above the sector median of 21.04, while P/B at 0.45 is below the sector median of 1.89.
• Profitability watchpoint: ROE of -2.89 and ROCE of -0.26 are below Healthcare benchmark medians of 10.7 and 13.16.
• Scale factor: Market capitalisation of Rs 42,898.76 crore is far above the supplied sector benchmark median of Rs 130.8 crore.

About Gland Pharma Ltd.

Based on the supplied dataset, Gland Pharma Ltd. is a listed Healthcare company traded under the symbol GLAND. In this article, the company is being analysed through the lens of a fresh 52-week high event, current market pricing, sector benchmark data and listed peer comparison rather than through unsupported operating detail.

The stock is part of the Healthcare sector benchmark that includes 202 companies in the same sector universe used for valuation and profitability comparison. That sector context is important because it helps investors judge whether Gland Pharma Ltd. Share Price is moving within a broadly comparable valuation range or standing out on metrics such as P/E, P/B, ROE and ROCE.

For readers following Gland Pharma Ltd. Company News or Gland Pharma Ltd. NSE and Gland Pharma Ltd. BSE search intent, the key takeaway is that the current focus is event-driven: the stock has reached a new yearly high, and the relevant analytical framework comes from price action, market capitalisation, peer comparison and Healthcare sector benchmarking available through Univest.

Track Gland Pharma Ltd. Share Price on Univest

Use Gland Pharma Ltd. (GLAND) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

On Univest, users can track Gland Pharma Ltd. Share Price Live, daily price moves, 52-week levels, market capitalisation and core valuation ratios in one place. That makes it easier to follow Gland Pharma Ltd. Share Price Today as it reacts to market conditions and appears in Stocks in News or Top Gainers Today screens.

Univest also helps investors monitor deeper context around Gland Pharma Ltd. Stock News, including peer comparison, sector analysis, shareholding pattern when available, and broader stock analysis metrics. For readers using Univest as a research workflow, the value lies in combining live market data with structured fundamental analysis and market context without turning the coverage into a recommendation.

As this 52-week peak shows, a stock can draw attention because of price action alone. Univest’s role is to help users track whether that attention continues to align with changes in valuation, profitability and relative positioning inside the Healthcare sector.

Frequently Asked Questions

What is the current Gland Pharma Ltd. Share Price today?

Ans. Gland Pharma Ltd. Share Price today is Rs 2635.4. The stock was up 1.34%, or Rs 34.95, from the previous close of Rs 2600.45 when this 52-week high article was generated on 10 August 2026.

What is the fresh 52-week high of Gland Pharma Ltd.?

Ans. The fresh 52-week high of Gland Pharma Ltd. is Rs 2675.15. The stock reached that one-year high during the session while trading in an intraday range of Rs 2610.1 to Rs 2675.15.

Why is Gland Pharma Ltd. Share Price rising today?

Ans. The supplied data confirms that Gland Pharma Ltd. Share Price is rising because the stock moved 1.34% higher and hit a fresh 52-week high. However, the verified dataset does not establish a separate company-specific catalyst.

What does today’s price action in GLAND show?

Ans. Today’s price action shows GLAND opened at Rs 2639.6, moved to a 52-week peak of Rs 2675.15, touched a low of Rs 2610.1, and stayed above the previous close, indicating sustained market attention.

What is the market capitalisation of Gland Pharma Ltd.?

Ans. Gland Pharma Ltd. has a market capitalisation of Rs 42,898.76 crore. That is significantly larger than the supplied same-sector benchmark median of Rs 130.8 crore and average of Rs 460.68 crore.

How is Gland Pharma Ltd. valued on P/E and P/B?

Ans. Gland Pharma Ltd. trades at a P/E ratio of 31.12 and a P/B ratio of 0.45. Its P/E is above the sector median of 21.04, while its P/B is below the sector median of 1.89.

What do the ROE and ROCE numbers indicate for Gland Pharma Ltd.?

Ans. The supplied profitability metrics show ROE at -2.89% and ROCE at -0.26. Both are below the Healthcare benchmark medians of 10.7 and 13.16, making returns an important metric to monitor.

How does Gland Pharma Ltd. compare with the supplied peers?

Ans. Gland Pharma Ltd. stands out mainly for size, with market capitalisation of Rs 42,898.76 crore versus about Rs 2513.58 crore to Rs 3032.97 crore for the supplied peers. Its P/B of 0.45 is also the lowest listed.

What sector does Gland Pharma Ltd. belong to?

Ans. Gland Pharma Ltd. belongs to the Healthcare sector. The sector snapshot in this article covers 202 same-sector companies, giving context for comparing valuation, profitability and market capitalisation against a broader listed universe.

Where can investors track Gland Pharma Ltd. Share Price updates?

Ans. Investors can track Gland Pharma Ltd. Share Price updates on Univest, including live price movement, 52-week levels, market cap, valuation ratios, peer comparison and broader stock analysis context linked to this fresh yearly high.